Clinical trial

Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy

NCT03661437

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention Actigraph Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Questionnaire Administration Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Systematic Light Exposure Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy

Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-09-24

PhaseEARLY_PHASE1

Conditions

Prostate Carcinomaverified · MONDO: prostate carcinoma

Interventions

ActigraphDEVICE

Questionnaire AdministrationOTHER

Systematic Light ExposurePROCEDURE

Sponsors & collaborators

City of Hope Medical Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

DuarteCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03661437 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.